18.88
price down icon2.43%   -0.47
after-market Dopo l'orario di chiusura: 18.98 0.10 +0.53%
loading

Seres Therapeutics Inc Azioni (MCRB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
8.65%
24.88
27.24 28.84 29.17 31.34
Operating Income/Loss
8.65%
-24.88
-27.24 -28.84 -29.17 -31.34
Nonoperating Income/Loss
91.61%
5.026
59.92 13.20 -21.86 -1.525
Income/Loss From Continuing Operations Before Tax
160.75%
-19.86
32.68 -15.64 -51.03 -32.87
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
160.75%
-19.86
32.68 -15.64 -51.03 -32.87
Income/Loss From Discontinued Operations, Net Of Tax
-
- - 139.81 -
Net Income/Loss
160.75%
-19.86
32.68 -15.64 88.78 -32.87
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.47%
8.7437
8.7032 5.3033 152.65 151.51
Diluted Average Shares
0.33%
8.7437
8.7147 5.3033 152.65 151.51
Basic Earnings Per Share
160.37%
-2.27
3.76 -0.11 0.58 -0.22
Diluted Earnings Per Share
160.53%
-2.27
3.75 -0.11 0.58 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):